{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:11:30Z","timestamp":1787026290255,"version":"build-2736575974"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T00:00:00Z","timestamp":1717977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Mucormycosis is an uncommon invasive fungal infection that has a high mortality rate in patients with severe underlying diseases, which leads to immunosuppression. Due to its rarity, determining the incidence and optimal treatment methods for mucormycosis in children is challenging. Metagenomic next-generation sequencing (mNGS) is a rapid, precise and sensitive method for pathogen detection, which helps in the early diagnosis and intervention of mucormycosis in children. In order to increase pediatricians\u2019 understanding of this disease, we conducted a study on the clinical features of mucormycosis in children and assessed the role of mNGS in its diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively summarized the clinical data of 14 children with mucormycosis treated at the First Affiliated Hospital of Zhengzhou University from January 2020 to September 2023.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of the 14 cases, 11 case of mucormycosis were classified as probable, and 3 cases were proven as mucormycosis. Most children (85.71%) had high-risk factors for mucormycosis. All 14 children had lung involvement, with 5 cases of extrapulmonary dissemination. Among the 14 cases, 4 cases underwent histopathological examination of mediastinum, lung tissue or kidney tissue, in which fungal pathogens were identified in 3 patients. Fungal hyphae was identified in 3 cases of mucormycosis, but only 1 case yielded a positive culture result. All patients underwent mNGS testing with samples from blood (8\/14), bronchoalveolar lavage fluid (6\/14), and tissue (1\/14). mNGS detected fungi in all cases: 7 cases had\n                      <jats:italic>Rhizomucor pusillus<\/jats:italic>\n                      , 4 cases had\n                      <jats:italic>Rhizopus oryzae<\/jats:italic>\n                      , 3 cases had\n                      <jats:italic>Rhizopus microsporus<\/jats:italic>\n                      , 1 case had\n                      <jats:italic>Lichtheimia ramosa<\/jats:italic>\n                      , and 1 case had\n                      <jats:italic>Rhizomucor miehei<\/jats:italic>\n                      . Coinfections were found with\n                      <jats:italic>Aspergillus<\/jats:italic>\n                      in 3 cases, bacteria in 3 cases, and viruses in 5 cases.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Children with mucormycosis commonly exhibit non-specific symptoms like fever and cough during the initial stages. Early diagnosis based on clinical symptoms and imaging is crucial in children suspected of having mucormycosis. mNGS, as a supplementary diagnostic method, offers greater sensitivity and shorter detection time compared to traditional mucormycosis culture or histopathological testing. Additionally, mNGS enables simultaneous detection of bacteria and viruses, facilitating timely and appropriate administration of antibiotics and thereby enhancing patient outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcimb.2024.1368165","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T16:25:52Z","timestamp":1718209552000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Clinical features of pediatric mucormycosis: role of metagenomic next generation sequencing in diagnosis"],"prefix":"10.3389","volume":"14","author":[{"given":"Yu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erhu","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiechao","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunli","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhua","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peisheng","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,6,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/j.1600-0463.2011.02728.x","article-title":"Retrospective assessment of beta-d-(1,3)-glucan for presumptive diagnosis of fungal infections","volume":"119","author":"Bellanger","year":"2011","journal-title":"Apmis"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.3201\/eid2007.140087","article-title":"Population-based analysis of invasive fungal infections, France 2001-2010","volume":"20","author":"Bitar","year":"2014","journal-title":"Emerg. Infect. Dis"},{"key":"B3","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s15010-011-0156-y","article-title":"The reversed halo sign as the initial radiographic sign of pulmonary zygomycosis","volume":"40","author":"Busca","year":"2012","journal-title":"Infection"},{"key":"B4","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1086\/430710","article-title":"Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer","volume":"41","author":"Chamilos","year":"2005","journal-title":"Clin. Infect. Dis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e405","DOI":"10.1016\/S1473-3099(19)30312-3","article-title":"Global guideline for the diagnosis and management of mucormycosis: an initiative of the european confederation of medical mycology in cooperation with the mycoses study group education and research consortium","volume":"19","author":"Cornely","year":"2019","journal-title":"Lancet Infect. Dis"},{"key":"B6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/1469-0691.12371","article-title":"Escmid and ecmm joint clinical guidelines for the diagnosis and management of mucormycosis 2013","author":"Cornely","year":"2014","journal-title":"Clin. Microbiol. Infect"},{"key":"B7","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1055\/s-00000075","article-title":"Mucormycosis: new developments into a persistently devastating infection","volume":"36","author":"Danion","year":"2015","journal-title":"Semin. Respir. Crit. Care Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3390\/jof9030307","article-title":"What is new in pulmonary mucormycosis","volume":"9","author":"Danion","year":"2023","journal-title":"J. Fungi (Basel)"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the european organization for research and treatment of cancer and\u00a0the\u00a0mycoses study group education and research consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin. Infect. Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s15010-018-1149-x","article-title":"Characteristics of pulmonary mucormycosis and predictive risk factors for the outcome","volume":"46","author":"Feng","year":"2018","journal-title":"Infection"},{"key":"B11","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/jpids\/pix107","article-title":"Mucormycosis in children: review and recommendations for management","volume":"7","author":"Francis","year":"2018","journal-title":"J. Pediatr. Infect. Dis. Soc"},{"key":"B12","doi-asserted-by":"publisher","first-page":"375","DOI":"10.5858\/2001-125-0375-HFOZ","article-title":"Histologic features of zygomycosis: emphasis on perineural invasion and fungal morphology","volume":"125","author":"Frater","year":"2001","journal-title":"Arch. Pathol. Lab. Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e01815","DOI":"10.1128\/mBio.01888-15","article-title":"Making the leap from research laboratory to clinic: challenges and opportunities for next-generation sequencing in infectious disease diagnostics","volume":"6","author":"Goldberg","year":"2015","journal-title":"Mbio"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-016-0326-8","article-title":"Next-generation sequencing diagnostics of bacteremia in septic patients","volume":"8","author":"Grumaz","year":"2016","journal-title":"Genome Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1146\/annurev-pathmechdis-012418-012751","article-title":"Clinical metagenomic next-generation sequencing for pathogen detection","volume":"14","author":"Gu","year":"2019","journal-title":"Annu. Rev. Pathol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"742","DOI":"10.2214\/AJR.17.18792","article-title":"Pulmonary mucormycosis: radiologic features at presentation and over time","volume":"210","author":"Hammer","year":"2018","journal-title":"Ajr Am. J. Roentgenol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"S245","DOI":"10.1093\/mmy\/myz011","article-title":"Pathogenicity patterns of mucormycosis: epidemiology, interaction with immune cells and virulence factors","volume":"57","author":"Hassan","year":"2019","journal-title":"Med. Mycol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1111\/myc.12428","article-title":"Delaying diagnostic procedure significantly increases mortality in patients with invasive mucormycosis","volume":"58","author":"Jeong","year":"2015","journal-title":"Mycoses"},{"key":"B19","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cmi.2018.07.011","article-title":"The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports","volume":"25","author":"Jeong","year":"2019","journal-title":"Clin. Microbiol. Infect"},{"key":"B20","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13613-021-00818-4","article-title":"Poor outcome associated with mucormycosis in critically ill hematological patients: results of a multicenter study","volume":"11","author":"Jestin","year":"2021","journal-title":"Ann. Intensive Care"},{"key":"B21","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.cmi.2016.01.005","article-title":"Mucormycosis in Australia: contemporary epidemiology and outcomes","volume":"22","author":"Kennedy","year":"2016","journal-title":"Clin.\u00a0Microbiol. Infect"},{"key":"B22","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.cmi.2016.03.029","article-title":"Initial use of combination treatment does not impact survival of 106 patients with haematologic Malignancies and mucormycosis: a propensity score analysis","volume":"22","author":"Kyvernitakis","year":"2016","journal-title":"Clin. Microbiol. Infect"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e101","DOI":"10.1086\/521245","article-title":"The value of computed tomography-guided percutaneous lung biopsy for diagnosis of\u00a0invasive fungal infection in immunocompromised patients","volume":"45","author":"Lass-Florl","year":"2007","journal-title":"Clin. Infect. Dis"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/j.cmi.2021.02.005","article-title":"Serology anno 2021-fungal infections: from invasive to chronic","volume":"27","author":"Lass-Florl","year":"2021","journal-title":"Clin. Microbiol. Infect"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/smtd.202000792","article-title":"High-throughput metagenomics for identification of pathogens in the clinical settings","volume":"5","author":"Li","year":"2021","journal-title":"Small Methods"},{"key":"B26","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jpeds.2021.05.016","article-title":"Invasive fungal infections in immunocompromised children: novel insight following a national study","volume":"236","author":"Olivier-Gougenheim","year":"2021","journal-title":"J. Pediatr"},{"key":"B27","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1186\/s12879-016-2005-1","article-title":"Invasive mucormycosis in children: an epidemiologic study in european and non-european countries based on two registries","volume":"16","author":"Pana","year":"2016","journal-title":"BMC Infect. Dis"},{"key":"B28","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1055\/s-2008-1063850","article-title":"Pulmonary zygomycosis","volume":"29","author":"Pyrgos","year":"2008","journal-title":"Semin. Respir. Crit. Care Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1086\/432579","article-title":"Epidemiology and outcome of zygomycosis: a review of 929 reported cases","volume":"41","author":"Roden","year":"2005","journal-title":"Clin. Infect. Dis"},{"key":"B30","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3390\/jof4030090","article-title":"Therapy of mucormycosis","volume":"4","author":"Sipsas","year":"2018","journal-title":"J. Fungi (Basel)"},{"key":"B31","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/mmy\/myx101","article-title":"Challenges in the diagnosis and treatment of mucormycosis","volume":"56","author":"Skiada","year":"2018","journal-title":"Med. Mycol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3390\/jof6040265","article-title":"Epidemiology and diagnosis of mucormycosis: an update","volume":"6","author":"Skiada","year":"2020","journal-title":"J. Fungi (Basel)"},{"key":"B33","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.idc.2021.03.009","article-title":"Mucormycosis","volume":"35","author":"Steinbrink","year":"2021","journal-title":"Infect. Dis. Clin. North Am"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e343","DOI":"10.1016\/S2666-5247(21)00148-8","article-title":"Mucormycosis: time to address this deadly fungal infection","volume":"2","author":"Stone","year":"2021","journal-title":"Lancet Microbe"},{"key":"B35","doi-asserted-by":"publisher","first-page":"S55","DOI":"10.1093\/cid\/cir868","article-title":"Early clinical and laboratory diagnosis of invasive pulmonary, extrapulmonary, and disseminated mucormycosis (zygomycosis)","author":"Walsh","year":"2012","journal-title":"Clin. Infect. Dis"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.949505","article-title":"Application of metagenomic next-generation sequencing in the diagnosis of pulmonary invasive fungal disease","volume":"12","author":"Wang","year":"2022","journal-title":"Front. Cell Infect. Microbiol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.977591","article-title":"Metagenomic next-generation sequencing indicates more precise pathogens in patients with pulmonary infection: a retrospective study","volume":"12","author":"Wu","year":"2022","journal-title":"Front. Cell Infect. Microbiol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"7509","DOI":"10.2147\/IDR.S393201","article-title":"Metagenomic next-generation sequencing for diagnostically challenging mucormycosis in patients with hematological Malignancies","volume":"15","author":"Zhang","year":"2022","journal-title":"Infect. Drug Resist"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.694756","article-title":"The diagnostic value of metagenomic next-generation sequencing in lower respiratory tract infection","volume":"11","author":"Zheng","year":"2021","journal-title":"Front. Cell Infect. Microbiol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/myc.13452","article-title":"Paediatric cutaneous mucormycosis: a case report and review of the literature","volume":"65","author":"Ziaka","year":"2022","journal-title":"Mycoses"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2024.1368165\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T16:25:56Z","timestamp":1718209556000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2024.1368165\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,10]]},"references-count":40,"alternative-id":["10.3389\/fcimb.2024.1368165"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2024.1368165","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,10]]},"article-number":"1368165"}}